Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BCTXF - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Receives Equity Investment to Support Novel Immunotherapy Clinical Research


BCTXF - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Receives Equity Investment to Support Novel Immunotherapy Clinical Research

  • Proprietary targeted immunotherapy technology personalized to match unmet needs of advanced breast cancer patients
  • Ongoing clinical studies of lead candidate, Bria-IMT, continue to show robust biological activity, excellent safety profile
  • Breast cancer is one of the most commonly diagnosed cancers, with 2.1 million new cases expected in 2018
  • Global cancer immunotherapy market is projected to be valued at nearly $145 billion by 2022

An equity investment of C$500,000 into BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) by the company’s recently-appointed director, Jamieson Bondarenko (http://nnw.fm/jSjK6), underscores the vital importance of BriaCell’s proprietary drug development efforts to millions of cancer patients. BriaCell is an immuno-oncology-focused biotechnology company dedicated to developing the first off-the-shelf, personalized immunotherapy that specifically targets the unmet medical needs of advanced breast cancer patients (http://nnw.fm/Xk3hH).

In a news release outlining the non-brokered private placement financing, the company said that net proceeds from the offering would be primarily used to finance BriaCell’s IIa combination study of...

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Stock Information

Company Name: BriaCell Therapeutics
Stock Symbol: BCTXF
Market: OTC
Website: briacell.com

Menu

BCTXF BCTXF Quote BCTXF Short BCTXF News BCTXF Articles BCTXF Message Board
Get BCTXF Alerts

News, Short Squeeze, Breakout and More Instantly...